Company Profile
What's New
Product Information
Applications Info
Tech Reference List
Information Request
Contact Us
Careers
Email Newsletter
Frequently Asked Questions
In Vitro Basics
In Vitro Toxicology Testing (Non-Animal Safety Testing)
Nanoparticle Research Using MatTek Human Tissue Constructs
Site Map
Search




MatTek Corporation
200 Homer Avenue
Ashland, MA  01721
508-881-6771
FAX:  508-879-1532
E-mail Us

Reproducibility Guaranteed!
Front page
Search

Category: Technical References, EpiAirway

562. ESTABLISHMENT OF A 3D AIRWAY MODEL FOR RESPIRATORY INFECTION.


Published by Battelle Memorial Institute. (2010). Summary:

Battelle utilizes the EpiAirway 3D respiratory tract tissue model for respiratory pathogen infection studies and for comparison of response to infection in the 3D in vitro tissue models derived from normal, asthmatic, smoker, and chronic obstructive pulmonary disease (COPD) donor tissues.

Battelle has demonstrated that the EpiAirway tissues can be cultured for extended periods up to 30 days without a significant loss in viability and with high precision.

After exposure/infection, cellular cytotoxicity has been quantified by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra-zolium bromide, a tetrazole) or biotoxicity assays and cytokine expression has been quantified by cytokine multiplex bead arrays using the Luminex-200 system.

Current studies are under way to evaluate the cytotoxic concentrations (CC50) and pathogen inhibitory concentrations (IC50) of several chemotherapeutic compounds.

When compared with infected tissues from healthy donors, the 3D airway tissues derived from patients who were asthmatic with COPD exhibited increased viral replication and enhanced infection-induced cellular toxicity and cytokine production.

Key Benefits:

Rapid screening for identification of lead compounds

Cost reduction associated with more thorough assessments prior to expensive pre-clinical animal studies

Model system for respiratory infections with either viral or bacterial etiologies

System in which to study bacterial/viral-induced disease exacerbations as occur in patients who were asthmatic with COPD

In vitro test system for anti-viral therapeutics and prophylactics

==================== Request an Electronic Copy (PDF format) of this Technical Paper ==================== EpiAirway Data Sheet EpiAirway Specifications EpiAirway Technical References


Keywords: Adenylate kinase, Asthmatic tissue, Chronic obstructive pulmonary disease (COPD), Cytokine expression, EpiAirway, GM-CSF, IL-1rá, IL-1á, IL-1â, IL-6, IL-8, IP-10, Influenza A, MCP-1, MCP-3, MIP-1á, MIP-1â, RANTES, Respiratory infection, Smoker tissue, TNF-á, Viral HA

Materials Tested: Influenza A virus



Top